Approval was backed by the ATTAIN program, including ATTAIN-1 (n= 3127), where Foundayo showed weight loss of 27.3 lbs (12.4%) vs 2.2 lbs (0.9%) with PBO at the highest dose, with overall loss of 25 lbs (11.1%) vs 5.3 lbs (2.1%), alongside reductions in CV risk markers across all doses About Foundayo (orforglipron) Foundayo is a once-daily small molecule (non-peptide) oral glucagon-like peptide-1 receptor agonist that can be taken any time of the day without restrictions on food and water intake
This is a decision that must be made in consultation with your medical provider
glass of water first thing in the a.m
What time of day should I inject
What is aspiration and why is it a concern during GLP-1 use
Nel corso dell'attivit sportiva aerobica o ad alta intensit, quando diventa utile ricavare maggiore energia dall'ossidazione dei grassi invece che dal glicogeno, questa molecolsa si attiva, stabilendo un legame con gli acidi grassi e favorendone il processo di Beta-Ossidazione , per la produzione della necessaria energia muscolare